Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer

Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer
Author :
Publisher :
Total Pages : 204
Release :
ISBN-10 : OCLC:796184637
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer by : Prajakta Shirish Oak

Download or read book Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer written by Prajakta Shirish Oak and published by . This book was released on 2012 with total page 204 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer Related Books

Development of Novel Combinatorial Treatment Strategies to Overcome Resistance in Breast Cancer
Language: en
Pages: 204
Authors: Prajakta Shirish Oak
Categories:
Type: BOOK - Published: 2012 - Publisher:

DOWNLOAD EBOOK

Overcoming Breast Cancer Therapy Resistance
Language: en
Pages: 390
Authors: Zodwa Dlamini
Categories:
Type: BOOK - Published: - Publisher: Springer Nature

DOWNLOAD EBOOK

Drug Resistance in Cancer: Mechanisms and Strategies
Language: en
Pages: 392
Authors: Sameer Ullah Khan
Categories:
Type: BOOK - Published: - Publisher: Springer Nature

DOWNLOAD EBOOK

Molecular Mechanisms of Drug Resistance And Strategies of Sensitization in Breast Cancer, 2nd edition
Language: en
Pages: 198
Authors: Yan Cheng
Categories: Medical
Type: BOOK - Published: 2024-01-11 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Basic scientific background Breast cancer is one of the most common cancer and the most frequent cause of cancer death among women worldwide. Currently, subtypi
Multi-Drug Resistance in Cancer
Language: en
Pages: 228
Authors: Rishabha Malviya
Categories: Medical
Type: BOOK - Published: 2023-07-18 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

MULTI-DRUG RESISTANCE IN CANCER The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents. Canc